InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: Carboat post# 279582

Saturday, 11/26/2016 12:06:54 AM

Saturday, November 26, 2016 12:06:54 AM

Post# of 346073
Peregrine Pharmaceuticals Buy Low then Sell High

We are at the buy low stage and CEO Steve King doing a great job on the science side and the wall street side will catch up once a deal is announced and that could be any day now.

Memorial Sloan Kettering Dr. Jedd Wolchok just validated PS Targeting and still have AstraZeneca and Merck trials with PS Targeting

Biomarkers are all the hype and PS Targeting biomarkers are coming... actually in December just 2 weeks ago

Has anyone heard about the exosome test kits?

Avid manufacturing expansions?


"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News